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Abdiction/Addiction
Connection
Sometimes in science, as in politics, con-
nections arise that may at first glance
appear to be strange bedfellows. That
might be the natural first impression of a
potential association between chemical
intolerance and addiction. But although
the conditions are manifested by behaviors
that appear to be polar opposites—sub-
stance avoidance (or abdiction, as some are
beginning to call it)
by the chemically
intolerant, and com-
pulsive substance use
by the addicted—
there is evidence to
suggest that, biologi-
cally, they may actu-
ally have much in
common. 
That was the con-
cept behind “Addic-
tion and Chemical
Intolerance: A Shared
Etiology?” This con-
ference, held 19–20
September 2005 in
Research Triangle
Park, North Carolina,
was the first scientific
meeting to be co-
sponsored by the
NIEHS and the Nat-
ional Institute on
Alcohol Abuse and
Alcoholism (NIAAA).
It was also the first
time researchers from
the fields of environ-
mental health and
addiction convened
to explore common
ground and potential
collaborations. 
“The idea of hosting a conference on
chemical intolerance and addiction stems
from a long history of individual physi-
cians’ reporting observations on patients
that looked like addiction to chemicals,
foods, caffeine, or alcoholic beverages,”
explained conference chair Claudia
Miller, a professor and researcher in envi-
ronmental medicine at The University of
Texas Health Science Center at San
Antonio. “There is a striking resemblance
between the symptoms and responses to
substances reported by chemically intoler-
ant patients and individuals addicted to
drugs or alcohol.”
Firm numbers on addiction and chemi-
cal intolerance are hard to come by, in part
because both conditions often go undiag-
nosed. Approximately 67% of all Americans
drink alcohol, yet 90% of the alcohol is
consumed by only 30% of the population,
said NIAAA director Ting-Kai Li in his
keynote address. In the latter half of 2003
(the most recent year for which figures are
available), there were 627,923 drug-related
emergency room visits in the United States,
according to the Drug Abuse Warning
Network of the U.S. Substance Abuse and
Mental Health Services Administration. As
for chemical intolerance, epidemiologic fig-
ures compiled and reported at the meeting
by William Meggs, a professor of emer-
gency medicine at East Carolina University,
suggest the prevalence of the condition (self-
reported) to be approximately 12% of the
U.S. population, with approximately 4%
self-reporting as “seriously affected.”
Miller contends that addiction and
chemical intolerance represent divergent
physiologic responses to a shared underly-
ing disease mechanism she calls toxicant-
induced loss of tolerance (TILT). In TILT,
a chemical exposure—either acute or
chronic and low-level—initiates sensitiza-
tion to even small amounts of structurally
diverse chemicals found in foods, drugs,
alcoholic and caffeinated beverages, pesti-
cides, mold toxins and other elements of
indoor air, implanted devices, solvents,
cleaning chemicals, and more. Thereafter,
when affected individuals are exposed to
everyday “triggering” substances such as
foods, traffic exhaust, or fragrances, they
report multisystem symptoms including
headache, nausea, difficulty breathing,
muscle spasms, and rashes. The fact
that different people
exhibit different con-
stellations of symp-
toms has made it
difficult to conduct
epidemiologic stud-
ies or arrive at a case
definition, Miller
says. In the past,
these difficulties have
led some observers to
speculate that chemi-
cal intolerance is psy-
chogenic in origin. 
As she outlined
in her presentation
to the approximate-
ly 120 attendees,
Miller postulates
that the TILT mech-
anism can lead to
either abdiction or
addiction, with both
behaviors intended
to avoid unpleasant
withdrawal symp-
toms. She further
proposes that TILT
may underlie a wide
variety of chronic
diseases that are
increasing in preva-
lence worldwide,
such as asthma,
autism, chronic fatigue syndrome,
fibromyalgia, and depression. (She
described these proposals in depth in an
article in the January 2001 issue of
Addiction.) 
Parallel Paths
Whether or not chemical intolerance and
addiction are flip sides of the same coin, it is
clear that researchers in the two fields have
much to learn from each other. Li said,
“Some people become alcohol-dependent
and then they recover because the environ-
mental risks have been removed; there’s a
gene–environment interaction. I think it’s
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environmentally induced condition, and
when you remove the environmental risk,
the person may still be genetically high-
risk, but without the environmental com-
ponent they can then recover.”
As things stand today, however, there
are no easy answers for the chemically intol-
erant. Environmental epidemiologist
Howard Hu daily perceives the need for
more research in his role as a clinician at the
Harvard School of Public Health. “Our
environmental medicine clinic has several
hundred patients who have this disorder,
and we have not made any progress in ways
to evaluate and manage them that has led to
any sustainable improvements in their con-
dition,” he said. “So we really appreciate the
need for good research that will shed light
on the biology of the disorder and allow us
to devise methods to manage and treat it.” 
Hu felt that the conference was a good
step forward in helping to define
a research agenda. “Some of the
approaches to chemical addic-
tion and alcoholism [research]
have provided a roadmap of
where the chemical intolerance
research needs to go, in terms of
understanding genetic suscepti-
bility and the molecular changes
that might be the mechanism of
how the intolerance phenotype
develops,” he said. One role
model for progress described by
Miller might be the Japanese
government, which has estab-
lished several environmentally controlled
medical units (EMUs) in hospitals for the
research, diagnosis, and treatment of chemi-
cal intolerance. To date, there is no compa-
rable facility in the United States. 
One speaker called attention to “tanta-
lizing morsels” of convergence that have
emerged between chemical intolerance and
addiction. For example, it appears all but
certain that genetic susceptibility plays an
important role in both conditions, and one
of the most compelling ideas to emerge
was the possibility that susceptibility to
both conditions may arise from polymor-
phisms in the same genomic neighbor-
hood—genes including CYP2D6, PON1,
and others that are known to regulate the
metabolism of exogenous agents such as
drugs and pesticides. PON1 is involved in
the detoxification of organophosphate pes-
ticides; CYP2D6 functions in the metabo-
lism of structurally diverse substances that
affect the central nervous system, including
various classes of antidepressants, ampheta-
mines, codeine, and neurotoxicants. The
question of whether variant alleles of these
genes give rise to the abdiction and addic-
tion phenotypes is a primary target for
investigation in the future. 
For now, case–control study results pre-
sented by researchers Cornelia Baines and
Gail McKeown-Eyssen of the University of
Toronto (which were published in the
October 2004 International Journal of
Epidemiology) clearly show an elevated risk
for chemical intolerance associated with
variations in the enzymatic metabolism
genes CYP2D6, PON1, and NAT2. A
gene–gene interaction detected between
CYP2D6 and NAT2 suggested that rapid
metabolism alleles in both genes may con-
fer as much as an 18-fold elevated risk for
chemical intolerance. These findings point
toward a biologic basis for the condition.
Brain imaging studies presented at the
conference by Hu, Marc Potenza of the Yale
University School of Medicine, and Leonid
Bunegin of The University of Texas Health
Science Center at San Antonio showed
striking similarities between chemically
intolerant patients and addicted individuals
in terms of the neural regions involved and
the types of activation detected. Many signs
point to the mesolimbic system, where the
activity of neurotransmitters such as
dopamine is regulated. Among individuals
who are genetically susceptible to either
chemical intolerance or addiction, the
homeostasis of the brain’s reward system
may be upset or perhaps changed perma-
nently by exposures to certain drugs or
chemicals. Thus, although the outcomes of
addiction and abdiction may be polar oppo-
sites, the underlying causes and mechanisms
may prove to be very similar.
You Say Tomato . . . 
Differences in nomenclature often pose a
challenge and require reconciliation
when two fields begin to work together.
As one conference presenter waggishly
put it, “Scientists would rather use each
other’s toothbrushes than use each
other’s terminology.” 
Perhaps the best example of varying
terminology arose as speakers from both
fields presented some of the leading
hypotheses in each field. In chemical intol-
erance, researchers refer to “initiation” (the
exposure that leads to the development of
intolerance) and “triggering” (subsequent
exposures resulting in symptoms); in
addiction research, scientists refer to neu-
rologic “sensitization” to a substance lead-
ing to “amplification” of its effects. 
According to Miller, future research
may show that neurologic sensitization also
explains initiation and triggering. “Perhaps
the processes [underlying addiction and
chemical intolerance] are one and the
same, but we don’t know that quite yet,”
she says. “Eventually, once the biology has
been worked out, the terminology may
reconcile, clarifying the links between the
two fields. It was one of the
most striking parallels to
emerge from the meeting.”
Another impediment dis-
cussed during the proceedings is
the longstanding struggle to
precisely define phenotypes of
chemical intolerance for
research purposes. Single-mind-
ed focus on this difficulty in the
past has been the excuse for
doing no research, said Miller,
who added that facilities like
Japan’s EMUs could be used to
assess individual responses in
the absence of any consensus on case defin-
itions or phenotypes. “Just as there is no
single case definition or phenotype that
encompasses all forms of drug and alcohol
addiction, there is no single case definition
that can be applied to all forms of abdic-
tion, because we are dealing with a general
mechanism for new classes of diseases that
have varied manifestations,” she explained. 
Establishing a chemical intolerance phe-
notype or case definition is further compli-
cated by a phenomenon called “masking.”
Underlying chemical or food triggers may be
masked by overlapping symptoms resulting
from simultaneous or sequential exposures
to other foods or chemicals, from addiction
to caffeine, alcohol, or tobacco, and from
varying degrees of habituation to triggering
substances. For example, Miller wrote in her
Addiction paper, “[i]f an individual is sensi-
tive to many different substances, then the
effects of everyday exposures to chemicals,
foods, or drugs may overlap, producing a
confusing array of symptoms. The individ-
ual would feel sick most of the time, but the
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T
here is a striking resemblance between
the symptoms and responses to substances
reported by chemically intolerant patients and
individuals addicted to drugs or alcohol.
–Claudia Miller
The University of Texas Health Science Center at San Antonioeffect of any single exposure would not be
apparent to either the individual or his
physicians.” Masking therefore confounds
diagnosis and treatment because clinicians
tend to address patients’ overt symptoms
without discovering the underlying intoler-
ances, much less the initiating exposures that
led to illness in the first place.
The lack of phenotypes may also ham-
per the application of systems biology to the
study of chemical intolerance. Systems biol-
ogy integrates tools from genomics, pro-
teomics, metabolomics, and informatics to
detect and validate novel biomarkers of dis-
ease. “Without a phenotype, it’s difficult to
move to the next level,” said William
Slikker, Jr., deputy center director for
research at the National Center for
Toxicological Research. First, he suggested,
we still need to define phenotypes in a way
in which they can be systematically exam-
ined. “Once that is done,” he said, “then I
can see setting hypotheses that can be tested
using the systems biology approach.”
At the same time, the availability of a
research EMU—the equivalent of a detox
unit for alcohol or drug withdrawal—would
provide a unique tool for examining individ-
uals’ genetic and protein expression before
and after removal of chemical and food trig-
gers and before and after specific challenges,
said Miller. “Just as systems biology will
enable researchers to understand individual
responses to complex environments, the
EMU is a tool that [would allow] us to iden-
tify the responses of individuals to a wide
variety of exposures,” she said. 
Miller said the approaches are complete-
ly compatible and complementary. “A clear
advantage of the EMU is that it can be done
now—well before sophisticated genomic
and proteomic approaches become widely
available—and begin to benefit patients
with a wide variety of environmentally
induced illnesses.”
The Road Ahead
NIEHS deputy director Samuel Wilson,
who opened the meeting, agreed that the
future of the field depends largely on
researchers’ ability to carefully identify
researchable questions. “It’s going to be up
to the scientists writing the proposals or
bringing the problems forward to figure out
experimental themes or researchable prob-
lems that they can make a case for, and then
work up and make solid discoveries on,” he
said. “There’s no substitute for having quan-
titative traits to look at—quantitative bio-
chemical markers or biomarkers that can be
related with exposure and with these very
complex behavioral phenotypes.” 
Wilson added that only when the mole-
cular science embedded in the pathophysi-
ology and biology of chemical intolerance
and addiction is uncovered will the extent
of overlap between the two conditions be
established. 
Several attendees expressed great inter-
est in pursuing collaborative projects with
colleagues from the other field, and many
were optimistic that the conference would
ultimately result in cross-institute initiatives
between the NIEHS and NIAAA. For envi-
ronmental health researchers, addiction has
long been a blind spot; in addiction
research, the same is true for environmental
exposures. With greater interactions
between the two fields, both may achieve a
clearer view of these conditions and the
road to health. –Ernie Hood
BEYOND THE BENCH
Nurses Adapt to
Changing Health
Care Climate
With increased emphasis being placed on
the importance of environmental health
comes the need for an expanded variety of
environmental health care practitioners.
Nursing is one of several professions that
are augmenting and advancing the capabil-
ities of their practitioners to meet this
need. Now the Community Outreach and
Education Program (COEP) of the
University of New Mexico’s Center for
Environmental Health Sciences has part-
nered with the New Mexico Environment
Department to create an environmental
health nursing internship as a component
of its outreach program. 
In cooperation with the university
College of Nursing, the partners recruit
nursing students who are interested in
implementing environmental health care
initiatives in the surrounding community.
For four years, the program has taken
nursing students beyond the traditional
curriculum and shown them firsthand how
interaction with environmental factors
affects human health. The pro-
gram also gives students valuable
experience in taking measures to
abate hazardous exposures in
communities. 
The interns are currently
working on a number of projects
that will affect different commu-
nity members. They are helping
to develop surveys and compiling
data for a project investigating
uranium exposure and subse-
quent kidney damage among the
Navajo Nation, whose members
live near and work in uranium
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Effecting change in Southwest communities.
Krystyn Yepa (right) is one of several nursing interns
working with Navajo and Sioux communities to
reduce exposures and increase knowledge through a
program of the University of New Mexico Center for
Environmental Health Sciences.mines. They are gathering and assembling
materials for a community education and
survey project on mercury in surface waters
and other environmental health concerns
among the Cheyenne River Sioux Tribe.
They are helping COEP staff write and
field-test an integrated environmental
health curriculum on diabetes for middle
school students. And in a fourth project,
they are helping to develop a best-practices
manual for applying farm waste fertilizer to
croplands in a way that minimizes human
exposure to aerosolized waste.
The local ties of some of the nursing
interns have enhanced the program’s role
as an effective community advocate. Intern
Krystyn Yepa is a Native American from
the Pueblo of Jemez who became interest-
ed in environmental health nursing
because she wanted to understand some of
the health effects in her tribe resulting
from exposure to different pollutants in
the environment. “Learning about the dif-
ferent environmental health problems that
exist in New Mexico has given me the
willpower to finish nursing school to ulti-
mately achieve my goal of improving the
health and lifestyles of my people by plac-
ing importance on the environment,” she
says. 
Yepa explains further, “As a Native
American, I was raised to respect and
appreciate the environment, and working
at the COEP has only strengthened my
values related to the environment.” She
also credits the internship with teaching
her important assessment tools that lay
emphasis on the environment when com-
pleting a health history on patients, some-
thing a traditional nursing internship
would not likely provide.
“The nursing interns have been an
incredible asset to our COEP,” says staff
member Stefani Hines. “It is a mutually
beneficial situation on many levels—the
student nurses gather valuable real-world
experiences in environmental health; the
nursing school has access to additional,
unique placements for their students; we
have additional support for projects, which
helps make them better; and the commu-
nities we work with benefit from the stu-
dents’ efforts as well.” 
Dedicated, enthusiastic environmental
health nursing interns will only continue
to play an important role in advancing the
COEP mission. One project currently in
development will help community mem-
bers get involved in city and county zoning
processes, which will both encourage a
healthy community mindset and minimize
exposures to pollutants. –Tanya Tillett
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Headliners Reproduction
NIEHS-Supported Research
Oocyte Generation in Adult Mice 
Johnson J, Bagley J, Skaznik-Wikiel M, Lee H-J, Adams GB, Niikura Y, Tschudy KS, Tilly
TC, Cortes ML, Forkert R, Spitzer T, Iacomini J, Scadden DT, Tilly JL. 2005. Oocyte genera-
tion in adult mammalian ovaries by putative germ cells in bone marrow and peripheral
blood. Cell 122:303–315.
The theory that female mammals are born with a finite number of germ
cells (oocytes) has been accepted as an unquestionable truth for over 50
years. Recent research has challenged this accepted dogma by showing
that mice and flies can produce oocytes and follicles during puberty and
adulthood. Now NIEHS grantee Jonathan L. Tilly and colleagues at the
Harvard Medical School have shown that adult mice can produce large
numbers of new oocytes in a short period of time, providing additional
evidence to challenge the accepted belief of a fixed complement of
oocytes at birth. The Harvard researchers also discovered a source of
germline stem cells in the bone marrow.
Oocytes are found in the ovaries surrounded by somatic cells in struc-
tures known as follicles. Only a small fraction of follicles actually reach
ovulation, producing an egg capable of being fertilized. Conventional wis-
dom hold that in humans, only about 30,000 of an original pool of about
1 million oocytes present at birth are still present at puberty, and this
number is thought to gradually decline throughout adulthood until the
complete loss of oocytes at around age 50 stimulates menopause.
Acceptance of the concept that adult mammals can continue to produce
oocytes has been slow, likely due to the lack of direct evidence of the exis-
tence of mammalian female germline stem cells.
The Harvard team conducted gene expression analysis and bone mar-
row transplantation studies on mice that had been sterilized through
chemotherapy. Within 24 hours of treatment, follicles were regrowing in
the animals’ ovaries. By 2 months after treatment, there was no difference
between the treated animals and controls. In other studies, mice whose
bone marrow was destroyed with chemotherapeutic agents were injected
with peripheral blood from transgenic animals with germline cells express-
ing green fluorescent protein. Oocytes found in the test animals’ ovaries
within 30 hours of treatment also expressed the fluorescent protein.
The researchers have not yet determined whether oocytes derived
from germline stem cells can undergo fertilization and subsequently devel-
op into viable offspring. However, the results do prove that bone marrow
and peripheral blood are sources of germline stem cells and can sustain
oocyte production into adulthood. If adult oocyte production is also possi-
ble in humans, it could have major implications for the treatment of infer-
tility and other disorders such as osteoporosis, although much additional
research is needed before this potential can be realized. –Jerry Phelps